InvestorsHub Logo
Followers 125
Posts 21098
Boards Moderated 0
Alias Born 06/13/2011

Re: ggwpq post# 347958

Saturday, 07/24/2021 7:28:42 PM

Saturday, July 24, 2021 7:28:42 PM

Post# of 428944
gg. NVS is not buying any biotech that’s lost their US patent . Why would they ?.
Since NVS is Swiss based there was probably a deal that could have been done re distribution of V with NVS’s existing EU sales team / infrastructure .

They obviously couldn’t come to terms with AMRN if there was any negotiations so we are now left with the cash burn associated with trying to launch there

Scripts have roughly gone sideways .. so far .. this year in the US … correct ?
Be interesting to see how much AMRN spent on sales reps and marketing to achieve that .

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News